← Leaderboards
William Bernard Brinkman
Cincinnati Childrens Hosp Med Ctr
$2,295,649
Attributed
$2,295,649
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $447.3K · FY2010–20$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$2,295,649 · 3
By mechanism
R34$1,417,500 · 2
K23$878,149 · 1
Top collaborators
No co-investigators on record.
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Avani C Modi$12,121,494
- Tanya E. Froehlich$6,634,365
- Peter A Margolis$5,160,019
- Kimberly Yolton$6,640,463
- Meghan Eileen McGrady$2,849,036
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignAttention Deficit Hyperactivity DisorderSkillsMedicinePharmaceutical PreparationsParentsChronicChildCaringStructureBasePrimary Health CareRecordsSymptomsInjuryImpairmentInnovationFamilyFoundationsPrimary Care SettingReportingSocialPhysiciansTraining
Grant awards (11)
Improving Medication Continuity among Adolescents with ADHD$159,000
R34 · FY2020 · MH · contact PI
Improving Medication Continuity among Adolescents with ADHD$198,750
R34 · FY2019 · MH · contact PI
Improving Medication Continuity among Adolescents with ADHD$357,750
R34 · FY2018 · MH · contact PI
Developing New Technologies to Improve ADHD Medication Continuity For PAR 12-279$195,000
R34 · FY2016 · MH · contact PI
Developing New Technologies to Improve ADHD Medication Continuity For PAR 12-279$234,000
R34 · FY2015 · MH · contact PI
Developing New Technologies to Improve ADHD Medication Continuity For PAR 12-279$273,000
R34 · FY2014 · MH · contact PI
Medication Continuity in Children Treated for ADHD$174,331
K23 · FY2014 · MH · contact PI
Medication Continuity in Children Treated for ADHD$173,459
K23 · FY2013 · MH · contact PI
Medication Continuity in Children Treated for ADHD$176,491
K23 · FY2012 · MH · contact PI
Medication Continuity in Children Treated for ADHD$176,676
K23 · FY2011 · MH · contact PI
Medication Continuity in Children Treated for ADHD$177,192
K23 · FY2010 · MH · contact PI